Hybribio (300639, SZ) will be at 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 25-27 in Anaheim, California, USA.

The Hybribio exhibit booth (No. 1482) will feature the latest nucleic acid diagnostic solutions covering reproductive health infection, neonatal and prenatal genetic diseases, respiratory tract infection and others. As the top HPV DNA test producer in China, Hybribio will introduce a series of certified HPV nucleic acid testing kits, which has greatly contributed to cervical cancer prevention and screening projects nationwide. In addition, Hybribio will also present self-developed laboratory consumables, including pipette tip, PCR consumables, deep-well place, tip comb and sample tubes.

To address current laboratory challenges, Hybribio will feature demonstrations of the Fully Automated Nucleic Acid Extraction System AutoPrep96, which could achieve a one-step workflow and enhance laboratory efficiency by reducing human errors.

► Product Features of HB-IEX96A

- Lip opening & closing

- Barcode scanning

- Tube loading

- Pipetting

- Nucleic acid extraction (Dual chamber)

- PCR setup

Hybribio Booth Design (No. 1482) 

■In-Booth Demonstration

July 25-26: 9:30 am-5:00 pm

July 27: 9:00 am-12:00 pm

To schedule an instrument demo or meet our representatives, please free to contact us through marketing@hybribio.com

About Hybribio

Founded in 2003, Hybribio (300639, SZ) is a leading nucleic acid test supplier and manufacturer who specializes in in-vitro diagnostic products with a fully integrated one-step operation chain from R&D, manufacturing, and sales & marketing to after-sales technical support services. Hybribio provides products including, but not limited to, HPV testing, reproductive health, genetic diseases, methylation, respiratory tract infection, pharmacogenetics and instrumentation.

For more information, please visit: www.hybribio.com